标题
Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro
作者
关键词
-
出版物
JOURNAL OF BONE AND MINERAL METABOLISM
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-10
DOI
10.1007/s00774-021-01206-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways
- (2020) Chang-hong Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline
- (2019) Richard Eastell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- CTLA4‐Ig directly inhibits osteoclastogenesis by interfering with intracellular calcium oscillations in bone marrow macrophages
- (2019) Hiroyuki Okada et al. JOURNAL OF BONE AND MINERAL RESEARCH
- T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-κB
- (2018) Jinglue Song et al. Biomed Research International
- Analysis of Ca2+ response of osteocyte network by three-dimensional time-lapse imaging in living bone
- (2017) Tomoyo Tanaka et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Parathyroid hormone regulates fates of murine osteoblast precursors in vivo
- (2017) Deepak H. Balani et al. JOURNAL OF CLINICAL INVESTIGATION
- Iguratimod prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator-activated receptor-γ
- (2017) Ying-Xing Wu et al. Molecular Medicine Reports
- Parathyroid Hormone (PTH) Induces Autophagy to Protect Osteocyte Cell Survival from Dexamethasone Damage
- (2017) Liang Zhu et al. MEDICAL SCIENCE MONITOR
- 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
- (2017) Lenore Buckley et al. Arthritis & Rheumatology
- Iguratimod (T-614) suppresses RANKL-induced osteoclast differentiation and migration in RAW264.7 cells via NF-κB and MAPK pathways
- (2016) Ke Gan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Advanced oxidation protein products induce apoptosis, and upregulate sclerostin and RANKL expression, in osteocytic MLO-Y4 cells via JNK/p38 MAPK activation
- (2016) Chaoqun Yu et al. Molecular Medicine Reports
- Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation
- (2016) T. Noguchi et al. OSTEOPOROSIS INTERNATIONAL
- Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients
- (2015) Yu Wei et al. Biomed Research International
- A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children
- (2014) Karen E. Hansen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro
- (2013) Shoichi Kaneshiro et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
- (2008) R. G. G. Russell et al. OSTEOPOROSIS INTERNATIONAL
- T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis
- (2008) Fang Du et al. ARTHRITIS RESEARCH & THERAPY
- Establishment of an Osteocyte-like Cell Line, MLO-Y4
- (2006) Yoichi Kato et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started